Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial

Sandro Barni,Gerardo Rosati,Sara Lonardi,Nicoletta Pella,Maria Banzi,Maria Giulia Zampino,Katia Fiorella Dotti,Lorenza Rimassa,Paolo Marchetti,Evaristo Maiello,Fabrizio Artioli,Daris Ferrari,Roberto Labianca,Paolo Bidoli,Alberto Zaniboni,Alberto Sobrero,Vincenzo Rosario Iaffaioli,Sabino De Placido,Gian Luca Frassineti,A. Ciarlo,Angela Buonadonna,Nicola Silvestris,E. Piazza,Lorenzo Pavesi,Mauro Moroni,Mario Clerico,Massimo Aglietta,Paolo Giordani,Francesca Galli,F. Galli,Fausto Petrelli

Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial

2020

Background:The risk of venous thromboembolic events (VTE) during adjuvant chemotherapy for colorectal cancer (CRC) is unknown. We aim to evaluate if the Khorana score (KS) can predict this risk, an...

Keywords:

Adjuvant
Oncology
Colorectal cancer
Medicine
Post-hoc analysis
Pathology
Internal medicine
adjuvant chemotherapy
Thrombosis
stage ii
thromboembolic risk

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations